We read the article by Zissimopoulos et al. with great interest [1]. They aimed to assess the role of Chromogranin A (CgA) in evaluating the disease activity and responsiveness to medical treatment...
No takes yet. Share an insight, caveat, or question.
Önal et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: